Armored GPC3 CAR-T Produces a Pediatric Solid Tumor Remission

Company Baylor College of Medicine and Texas Children’s Hospital Event Type Peer-Reviewed Case Report Modality Autologous CAR-T (Cytokine-Armored, IL-15/IL-21 Coexpression) Target GPC3 (Glypican-3) Disease Area Chemotherapy-Resistant Metastatic Hepatoblastoma Summary A peer-reviewed New England Journal of Medicine case report described complete regression of chemotherapy-resistant metastatic hepatoblastoma…